Tag: Cardiology
-
Arrhythmia Genes More Common Than Previously Thought
Sequencing known cardiac arrythmia genes in more than 20,000 people without an indication for genetic testing identified pathogenic variants in nearly one percent of individuals.
-
Response to Exercise is Key to Novel Device Therapy for the Most Common Type of Heart Failure
A new Northwestern Medicine study suggests that some patients with the most common type of heart failure may benefit from a novel, minimally invasive cardiac implant device called an atrial shunt.
-
Remembering Jeremiah Stamler, MD, Founding Chair and Professor Emeritus of Preventive Medicine
Jeremiah Stamler, MD, founding chair and professor emeritus of Preventive Medicine, passed away on January 26. He was 102 years old.
-
Without Coronary Calcium, Risk Factors Impact Cardiovascular Disease
Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension have the highest risk of cardiovascular disease events, according to a recent study.
-
First Model to Predict Lifetime Risk of Heart Failure
A new Northwestern Medicine study has, for the first time, derived and validated a set of risk prediction models for lifetime risk of heart failure.
-
Effectiveness of Subcutaneous Defibrillators
Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a recent study.
-
Statins Cost-Effective in Young Adults
Statin therapy has been shown cost-effective for lowering cholesterol in young adults, according to a study published in the Journal of the American College of Cardiology.
-
Drug May Benefit Patients with Heart Failure
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved heart failure-related symptoms and physical limitations in patients with heart failure with preserved ejection fraction.
-
Drug May Improve Cardiac Function in Hypertrophic Cardiomyopathy
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to a recent clinical trial.
-
Lloyd-Jones Testifies in Support of Cardiovascular Health Legislation
Donald Lloyd-Jones, MD, ScM, chair of Preventive Medicine and the Eileen M. Foell Professor of Heart Research, and current president of the American Heart Association, recently testified before Congress in support of legislation that would improve cardiovascular health in the U.S.
